Back
Incyte Vs. Biomarin Pharmaceutical Industry Stock Comparison
Buy
64
INCY
Incyte
Last Price:
77.29
Seasonality Move:
35.45%
Buy
54
BMRN
Biomarin Pharmaceutical
Last Price:
66.06
Seasonality Move:
13.3%
Buy
64
Incyte (INCY)
is a Buy
Is Incyte a Buy, Sell or Hold?
- The current Incyte [INCY] share price is $77.28. The Score for INCY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- INCY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $66.04. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $66.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
INCY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.72 | Buy |
| Relative Strength Index (14 RSI): | 80.26 | Buy |
| Chaikin Money Flow: | 1140547 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.25 - 72.25) | Buy |
| Bollinger Bands (100): | (61.18 - 68.26) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.96 | Sell |
| Relative Strength Index (14 RSI): | 29.66 | Sell |
| Chaikin Money Flow: | 826493 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.58 - 70.68) | Sell |
| Bollinger Bands (100): | (71.66 - 88.44) | Sell |
INCY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.7 | Buy |
| 20-day SMA: | 68.51 | Buy |
| 50-day SMA: | 66.46 | Buy |
| 200-day SMA: | 60.94 | Buy |
| 8-day EMA: | 73.42 | Buy |
| 20-day EMA: | 70.01 | Buy |
| 50-day EMA: | 67.15 | Buy |
| 200-day EMA: | 63.04 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 67.62 | Sell |
| 20-day SMA: | 69.09 | Sell |
| 50-day SMA: | 74.56 | Sell |
| 200-day SMA: | 82.71 | Sell |
| 8-day EMA: | 67.29 | Sell |
| 20-day EMA: | 68.99 | Sell |
| 50-day EMA: | 73.26 | Sell |
| 200-day EMA: | 81.42 | Sell |
Incyte Earnings Growth & INCY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.29 per share, and an increase next year of $4.72 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.
Incyte Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||